Acadia Pharmaceuticals Inc (ACAD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ACAD? Forum Prognose

Finanzdaten der Acadia Pharmaceuticals Inc-Aktie (ACAD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.92% 283.99	278.63	264.57	244.32	250.40
Cost Of Revenue	21.15% 26.23	21.65	20.73	20.39	18.86
Gross Profit	0.30% 257.76	256.99	243.83	223.93	231.54
Operating Expenses	8.65% 240.37	221.23	211.46	204.63	199.90
Benefits Costs and Expenses	10.10% 257.67	234.04	224.35	216.54	211.59
Costs And Expenses	9.77% 266.60	242.88	232.19	225.03	218.76
Operating Income/Loss	51.36% 17.39	35.76	32.37	19.29	31.64
Income/Loss From Continuing Operations Before Tax	40.98% 26.32	44.59	40.21	27.78	38.81
Income Tax Expense/Benefit	809.54% -247.25	-27.18	13.54	8.792	6.041
Income/Loss From Continuing Operations After Tax	281.13% 273.57	71.78	26.67	18.99	32.77
Net Income/Loss	281.13% 273.57	71.78	26.67	18.99	32.77
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.69% 0.519	168.84	167.83	166.81	165.97
Diluted Average Shares	99.55% 0.763	170.65	168.68	167.67	166.18
Basic Earnings Per Share	276.74% 1.62	0.43	0.16	0.11	0.20
Diluted Earnings Per Share	283.33% 1.61	0.42	0.16	0.11	0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%